ALF Elects New Chairman to Its National Board of Directors
The American Liver Foundation (ALF) announced today the appointment of Nicholas DeRoma as the new chairman of the ALF’s National Board of Directors.
“After nearly five years as the chairman of ALF’s Board, I could not be more proud to pass the baton to Nick,” said Thomas F. Nealon III, chief executive officer of the American Liver Foundation. “He has immersed himself in every aspect of our organization, and brings tremendous passion and commitment to the ALF and its mission.”
DeRoma has served on the National Board of Directors for the ALF for ten years, and is also a member of the Executive Committee and the co-chair of the Audit Committee.
“I am very honored to serve as the new chairman of the National Board of Directors,” said Nicholas DeRoma. “I look forward to continuing our commitment to supporting and offering hope to millions of people affected by liver disease.”
DeRoma is a former partner and current member of the Advisory Board of Rosenzweig & Company, an executive search firm, and prior to retirement in 2012, he served as the executive vice president and chief legal and compliance officer for Alcoa, Inc. Prior to his tenure at Alcoa, he served as the executive vice president and chief legal and compliance officer for Nortel Networks, Inc., and was employed by the IBM Corporation for 25 years, serving as the general counsel of IBM North America, the general counsel of IBM Europe-Middle East-Africa, and the general counsel of IBM Asia.
Nicholas DeRoma is a graduate of William & Mary Law School, and received his bachelor’s degree in finance, from the University of Connecticut. In addition, he was awarded an Executive MBA from the Harvard Business School at Harvard University.
Share this page